“Qingfei Paidu Decoction”—A Possible Choice of Phytotherapy for Severe Acute Respiratory Infection Caused by Coronavirus Disease-19

• 作者: Qian Deng
• 来源期刊: 美国植物学期刊(英文)
• 学科: 医学
• 关键词: Qingfei Paidu Decoction COVID-19 COPD PHARMACOLOGY THERAPEUTICS
• 年，卷（期）: mgzwxqkyw_2020,（7）
• 页码范围: 1111-1136
• 页数: 26页
• 分类号: R28

摘要

This work is aimed to study the therapeutics and pharmacology of the treatment of severe acute respiratory infection caused by coronavirus disease-19 (COVID-19) with traditional Chinese medicine (TCM) “Qingfei Paidu Decoction”. We analyze the “Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia” (Version I to Version VII) made by China, “Clinical management of severe acute respiratory infection when novel coronavirus <span style="font-family:Verdana;">(2019-nCoV) infection is suspected—Interim guidance” made by World Healt</span><span style="font-family:Verdana;">h Organization (WHO), “Therapeutic Guidelines: Respiratory” published by Australia, and the origin of classical prescription of Qingfei Paidu Decoction: “Shanghan Lun (Treatise on Febrile Diseases)” and “Jinkui Yaolue (Synopsis of Golden Chamber)”. We search the dictionary of traditional Chinese medicine (Version II) manually. We search literatures from 2001 to 2020 on Wiley online library. We conduct a comparative study on the therapeutic options and indications among Qingfei Paidu Decoction, COVID-19 and chronic obstructive pulmonary disease (COPD). And we carry out pharmacological inquiry of Qingfei Paidu Decoction. The therapeutic options and indications of Qingfei Paidu Decoction in China, COVID-19 and COPD are considered to be basically consistent. Qingfei Paidu Decoction has a definite therapeutic effect on the symptoms, basic diseases and complications for COVID-19 and COPD. Qingfei Paidu Decoction is a possible choice of </span><span style="font-family:Verdana;">phytotherapy </span><span style="font-family:Verdana;">for severe acute respiratory infection caused by COVID-19.</span>